Stereotaxis (STXS) director receives 46,948 restricted stock units in grant

Rhea-AI Filing Summary

Stereotaxis, Inc. reported an equity award to a company director. On 01/02/2026, the director received 46,948 shares of common stock as a grant of restricted share units at a stated price of $0 per share. Following this grant, the director beneficially owned 578,145 shares of Stereotaxis common stock in direct ownership.

The filing explains that each restricted share unit represents the right to receive one share of common stock. These units vest on the earliest of three events: the fifth anniversary of the award date, the date the director’s board service ends, or a defined Change of Control under the award documents. The report is signed by an attorney-in-fact for director Ross B. Levin, indicating this is routine insider equity compensation rather than a market sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levin Ross B

(Last) (First) (Middle)

C/O STEREOTAXIS, INC.

710 NORTH TUCKER BOULEVARD; SUITE 110

(Street)

ST. LOUIS, MO 63101

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		46,948(1)	A	$0	578,145	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

	/s/ Kimberly R. Peery, Attorney-in Fact for Ross B. Levin	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Stereotaxis (STXS) disclose in this filing?

The filing reports that a Stereotaxis director received a grant of 46,948 restricted share units, each representing one share of common stock, on 01/02/2026 at a stated price of $0 per share.

How many Stereotaxis (STXS) shares does the director own after this grant?

After the reported transaction, the director beneficially owned 578,145 shares of Stereotaxis common stock in direct ownership.

How do the Stereotaxis (STXS) restricted share units for the director vest?

The restricted share units vest on the earliest of five years from the award date, the date the director’s service on the board ends, or a Change of Control as defined in the award documents.

What does each restricted share unit granted by Stereotaxis (STXS) represent?

Each restricted share unit represents a right to receive one share of Stereotaxis common stock upon vesting, according to the explanation in the filing.

Who is the Stereotaxis (STXS) insider involved in this equity grant?

The signature block identifies Ross B. Levin as the reporting person, with the form signed by Kimberly R. Peery as attorney-in-fact on his behalf.

Is the reporting person a director or officer of Stereotaxis (STXS)?

The form indicates the reporting person’s relationship to Stereotaxis as a Director, with that box checked on the relationship line.